EUVIMEDEUVIMED entdecken
Crossref

H3K27 acetylation activated‐CD109 evokes 5‐fluorouracil resistance in gastric cancer via the JNK / MAPK signaling pathway

Fei Zhou, Leiming Wang, Han Ge iD, Diancai Zhang, Weizhi Wang

Environmental Toxicology · 2023

DOI: 10.1002/tox.23919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2023. Verfasst von Fei Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, The Affiliated Shuyang Hospital of Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Fluorouracil, Stomach Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance is a considerable obstacle to gastric cancer (GC) treatment. The current work aimed to elucidate the functional mechanism of CD109 in 5‐fluorouracil (5‐FU) resistance in GC. In this study, we demonstrated that CD109 was extremely heightened in 5‐FU‐resistant GC cells. CD109 deficiency lessened the IC 50 value, impaired cell viability and metastatic capability, and induced cell apoptosis after 5‐FU treatment in cells. In addition, we found that PAX5 bound p300 increased the enrichment of H3K27ac at the promoter region of the CD109 gene, which resulted in the upregulation of CD109 in GC. Moreover, we also revealed that CD109 triggered 5‐FU resistance via activating the JNK/MAPK signaling. Blockage of JNK/MAPK signaling using JNK inhibitor, SP600125, abolished CD109 upregulation‐induced changes of IC 50 values, cell viability, metastasis and apoptosis in NCI‐N87/5‐FU and SNU‐1/5‐FU cells. Importantly, CD109 silencing enhanced the therapeutic efficacy of 5‐FU, leading to reduced tumor growth in vivo. In conclusion, our results unveiled that H3K27 acetylation activated‐CD109 enhanced 5‐FU resistance of GC cells via modulating the JNK/MAPK signaling pathway, which might provide an attractive therapeutic target for GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorouracilStomach NeoplasmsHumansAcetylationCell Line, TumorApoptosisMAP Kinase Signaling SystemDrug Resistance, NeoplasmCell ProliferationNeoplasm ProteinsAntigens, CDGPI-Linked Proteins

Stichwörter der Autor:innen

5-fluorouracilCD109H3K27 acetylationJNK/MAPKgastric cancer

Substanzen

FluorouracilCD109 protein, humanNeoplasm ProteinsAntigens, CDGPI-Linked Proteins

Autor:innen und Institutionen

  • Department of Gastric Surgery, The Affiliated Shuyang Hospital of Xuzhou Medical University, Xuzhou, China.
  • Department of Gastric Surgery, Jiangsu Provincial People's Hospital, Nanjing, China.

ORCID-Profile: Han Ge

Zitieren

APA

Zhou, F., Wang, L., Ge, H., Zhang, D., & Wang, W. (2023). H3K27 acetylation activated‐CD109 evokes 5‐fluorouracil resistance in gastric cancer via the JNK / MAPK signaling pathway. Environmental Toxicology. https://doi.org/10.1002/tox.23919

Vancouver

Zhou F, Wang L, Ge H, Zhang D, Wang W. H3K27 acetylation activated‐CD109 evokes 5‐fluorouracil resistance in gastric cancer via the JNK / MAPK signaling pathway. Environmental Toxicology. 2023. doi:10.1002/tox.23919

BibTeX
@article{Zhou2023,
  author = {Zhou, Fei and Wang, Leiming and Ge, Han and Zhang, Diancai and Wang, Weizhi},
  title = {H3K27 acetylation activated‐CD109 evokes 5‐fluorouracil resistance in gastric cancer via the JNK / MAPK signaling pathway},
  journal = {Environmental Toxicology},
  year = {2023},
  doi = {10.1002/tox.23919}
}
Kostenlos starten →